CRH Reports Record 2025 Results, Raises Dividend 5%, and Provides Strong 2026 Outlook
CRH sits 59% above its 52-week low of $76.75.
Summary
CRH announced record financial results for fiscal year 2025, including double-digit growth in Adjusted EBITDA and EPS, alongside a 5% increase in its quarterly dividend and positive guidance for 2026.
Key Events · Earnings and Guidance · CRH
-
Record 2025 Financial Performance
CRH reported full year 2025 total revenues of $37.4 billion (+5% YoY), net income of $3.8 billion (+8% YoY), Adjusted EBITDA of $7.7 billion (+11% YoY), and diluted EPS of $5.51 (+10% YoY), reflecting strong underlying operating performance and margin expansion.
-
Positive 2026 Outlook and Guidance
The company provided a positive outlook for 2026, expecting further growth with Net income between $3.9 billion and $4.1 billion, Adjusted EBITDA between $8.1 billion and $8.5 billion, and diluted EPS between $5.60 and $6.05.
-
Increased Quarterly Dividend
CRH declared a quarterly dividend of $0.39 per share, representing a 5% increase over the prior year, to be paid on April 8, 2026.
-
Significant Strategic Acquisitions
In 2025, CRH invested $4.1 billion in 38 value-accretive acquisitions, including the $2.1 billion acquisition of Eco Material Technologies, strengthening its market leadership and exposure to infrastructure megatrends.
Analysis · CRH · Manufacturing
CRH Public Limited Company announced robust financial performance for fiscal year 2025, marked by record revenues, net income, and Adjusted EBITDA, demonstrating strong operational execution and market leadership. The positive 2026 guidance, coupled with significant strategic acquisitions, signals continued growth momentum. The 5% increase in the quarterly dividend underscores the company's financial health and commitment to shareholder returns. Additionally, the review of its London Stock Exchange listing and preference share structure indicates a strategic move to streamline its corporate structure, with its primary NYSE listing remaining unaffected.
At the time of this filing, CRH was trading at $122.41 on NYSE in the Manufacturing sector, with a market capitalization of approximately $83.5B. The 52-week trading range was $76.75 to $131.55. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.